Luxottica Group (OTCMKTS:LUXTY) & RxSight (NASDAQ:RXST) Head-To-Head Review

Luxottica Group (OTCMKTS:LUXTYGet Rating) and RxSight (NASDAQ:RXSTGet Rating) are both consumer discretionary companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, risk, institutional ownership, profitability and valuation.

Profitability

This table compares Luxottica Group and RxSight’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Luxottica Group N/A N/A N/A
RxSight -212.04% -251.55% -37.22%

Valuation & Earnings

This table compares Luxottica Group and RxSight’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Luxottica Group $10.34 billion 2.62 $1.17 billion $2.29 24.37
RxSight $22.59 million 15.30 -$48.69 million ($5.43) -2.31

Luxottica Group has higher revenue and earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than Luxottica Group, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Luxottica Group and RxSight, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Luxottica Group 0 0 0 0 N/A
RxSight 0 0 6 0 3.00

RxSight has a consensus target price of $19.83, indicating a potential upside of 57.78%. Given RxSight’s higher possible upside, analysts plainly believe RxSight is more favorable than Luxottica Group.

Institutional and Insider Ownership

0.1% of Luxottica Group shares are owned by institutional investors. Comparatively, 31.6% of RxSight shares are owned by institutional investors. 75.0% of Luxottica Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Luxottica Group beats RxSight on 8 of the 12 factors compared between the two stocks.

Luxottica Group Company Profile (Get Rating)

Luxottica Group S.p.A., together with its subsidiaries, provides fashion, luxury, sports, and performance eyewear worldwide. It operates through two segments, Manufacturing and Wholesale Distribution, and Retail Distribution. The Manufacturing and Wholesale Distribution segment engages in the design, manufacture, distribution, and marketing of proprietary and designer lines of prescription frames and sunglasses. This segment offers its products under proprietary brands, such as Ray-Ban, Oakley, Persol, Oliver Peoples, Alain Mikli, Arnette, and Vogue Eyewear; and licensed brands, including Giorgio Armani, Emporio Armani, Armani Exchange, Brooks Brothers, Burberry, Bulgari, Chanel, Coach, Dolce&Gabbana, DKNY, Michael Kors, Paul Smith Spectacles, Prada, Miu Miu, Ralph Lauren, Polo Ralph Lauren, Ralph, Starck Eyes, Tiffany & Co, Tory Burch, Valentino, Versace, and Ferrari. The Retail Distribution segment operates prescription eyewear stores primarily under its retail brands, including LensCrafters, Sunglass Hut, Pearle Vision, OPSM, Laubman & Pank, GMO, David Clulow, Salmoiraghi & ViganĂ², Ray-Ban, Oakley and Vault, Oliver Peoples, Alain Mikli, Ilori Optical, and Optical Shop of Aspen; and licensed brands, such as Sears Optical and Target Optical. As of December 31, 2017, it operated approximately 9,000 stores. The company was founded in 1961 and is headquartered in Milan, Italy. As of October 1, 2018, Luxottica Group S.p.A. operates as a subsidiary of EssilorLuxottica.

RxSight Company Profile (Get Rating)

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Receive News & Ratings for Luxottica Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luxottica Group and related companies with MarketBeat.com's FREE daily email newsletter.